Peder Jensen, Director at BIOCRYST PHARMACEUTICALS INC (BCRX), bought 20,000 shares at $1.51 ($30K) on 2012-12-14, disclosed to the SEC on 2012-12-17.
Open-market purchase of $30k BCRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| BCRX | BUY | 2012-06-05 | $64K | — | Filing → |
| BCRX | BUY | 2011-11-18 | $28K | — | Filing → |
| BCRX | BUY | 2011-05-16 | $36K | — | Filing → |